Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Conference News ESC 2025

BaxHTN: Baxdrostat Lowers BP in Uncontrolled and Resistant Hypertension

Todd Neale

August 31, 2025

News Opinion Editor's Corner ESC 2025

What’s Going to Be Hot at ESC Congress 2025?

Michael O'Riordan

August 25, 2025

News Conference News ESC 2024

New ESC Guidelines on BP and Hypertension Shift Treatment Targets Lower

Yael L. Maxwell

September 04, 2024

Presentation ESC 2024

QUADRO Phase III Study: Efficacy and Safety of the new Quadruple SPC Perindopril/Indapamide/Amlodipine/Bisoprolol in Patients with Resistant Hypertension

Presenter: Stefano Taddei

August 31, 2024

News Conference News ESC 2024

Polypills Show Promise in Diverse Hypertensive Patient Groups

L.A. McKeown

August 31, 2024

News Conference News ESC 2022

TIME of Antihypertensive Dose Doesn’t Matter for CV Protection

Todd Neale

August 26, 2022

News Conference News ESC 2017

Renal Denervation: Proof-of-Concept Study Gives Fresh Jolt to Fizzled Field

Todd Neale

August 28, 2017

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Conference News ESC 2013

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

Caitlin E. Cox

September 04, 2013

News Conference News ESC 2012

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

August 29, 2012

Advertisement

BaxHTN: Baxdrostat Lowers BP in Uncontrolled and Resistant Hypertension

What’s Going to Be Hot at ESC Congress 2025?

New ESC Guidelines on BP and Hypertension Shift Treatment Targets Lower

QUADRO Phase III Study: Efficacy and Safety of the new Quadruple SPC Perindopril/Indapamide/Amlodipine/Bisoprolol in Patients with Resistant Hypertension

Polypills Show Promise in Diverse Hypertensive Patient Groups

TIME of Antihypertensive Dose Doesn’t Matter for CV Protection

Renal Denervation: Proof-of-Concept Study Gives Fresh Jolt to Fizzled Field

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content